tiprankstipranks

Kyrylo Ponomarenko - New Portfolio

Kyrylo Ponomarenko

Kyrylo Ponomarenko
Individual Investor
Ranked #446,238 out of 731,863 TipRanks' Investors
Success Rate
25%
23 out of 94
profitable transactions
Average Return
-15.58%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 661.44%
6-Month Return▲ 2972.54%
12-Month Return▲ 10376.45%
YTD Return▲ 1080.70%
Total Return▲ 3802.89%

Best Trade

Opened at
Closed at
Gain▲ 221.70%

Bio

Portfolio

Performance

712.88%0-712.88%
▼ 6.45%
▼ 2.17%
▲ 404.39%
Oct 2023
▲ 9.22%
▲ 9.13%
▲ 201.27%
Nov 2023
▲ 5.14%
▲ 4.57%
▼ 0.11%
Dec 2023
▼ 1.87%
▲ 1.59%
▲ 1.33%
Jan 2024
▲ 14.08%
▲ 5.22%
▲ 28.95%
Feb 2024
▲ 5.05%
▲ 3.27%
▲ 6.28%
Mar 2024
▼ 12.40%
▼ 4.03%
▲ 712.88%
Apr 2024
▲ 5.14%
▲ 0.61%
▲ 4.59%
May 2024
TipRanks AverageS&P 500Investor Portfolio
▼ 6.45%▼ 2.17%▲ 404.39%
▲ 9.22%▲ 9.13%▲ 201.27%
▲ 5.14%▲ 4.57%▼ 0.11%
▼ 1.87%▲ 1.59%▲ 1.33%
▲ 14.08%▲ 5.22%▲ 28.95%
▲ 5.05%▲ 3.27%▲ 6.28%
▼ 12.40%▼ 4.03%▲ 712.88%
▲ 5.14%▲ 0.61%▲ 4.59%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
x6ontznlzt
x6ontznlzt
x6ontznlzt
x6ontznlzt
x6ontznlzt
x6ontznlzt
x6ontznlzt
fupd0009thg
fupd0009thg
fupd0009thg
fupd0009thg
fupd0009thg
fupd0009thg
fupd0009thg
wbwplyjpzs
wbwplyjpzs
wbwplyjpzs
wbwplyjpzs
wbwplyjpzs
wbwplyjpzs
wbwplyjpzs
rfp0o67nn
rfp0o67nn
rfp0o67nn
rfp0o67nn
rfp0o67nn
rfp0o67nn
rfp0o67nn
el2s1f8jtum
el2s1f8jtum
el2s1f8jtum
el2s1f8jtum
el2s1f8jtum
el2s1f8jtum
el2s1f8jtum
pivt7cn
pivt7cn
pivt7cn
pivt7cn
pivt7cn
pivt7cn
pivt7cn
ypwq3hchu1
ypwq3hchu1
ypwq3hchu1
ypwq3hchu1
ypwq3hchu1
ypwq3hchu1
ypwq3hchu1
aqks2q
aqks2q
aqks2q
aqks2q
aqks2q
aqks2q
aqks2q
ukasfyqm3eh
ukasfyqm3eh
ukasfyqm3eh
ukasfyqm3eh
ukasfyqm3eh
ukasfyqm3eh
ukasfyqm3eh
7f0hsoklw5o
7f0hsoklw5o
7f0hsoklw5o
7f0hsoklw5o
7f0hsoklw5o
7f0hsoklw5o
7f0hsoklw5o
To view investors' portfolios
Sign Up For Free
SomaLogic
▼ 81.79%
2
Close
Jan 05, 2024
Standard BioTools
0.77%
▲ 35.29%
1
Buy
Jan 05, 2024
Triterras
11.72%
▼ 99.67%
5
Buy
Jan 15, 2022
Equillium
▼ 44.22%
2
Close
Jan 15, 2022
Merck & Company
▲ 16.20%
2
Close
Jan 15, 2022
Crispr Therapeutics AG
▼ 40.76%
2
Close
Jan 15, 2022
Intel
▼ 13.16%
2
Close
Jan 15, 2022
FTAI Aviation
▲ 12.50%
3
Close
Jan 15, 2022
Genocea Biosciences
▼ 20.78%
2
Close
Oct 29, 2021
Galmed Pharmaceuticals
▼ 29.02%
3
Close
Oct 29, 2021
ObsEva
▼ 20.81%
3
Close
Oct 29, 2021
Bioxcel Therapeutics
▼ 24.28%
4
Close
Oct 29, 2021
Bioline RX Ltd Sponsored ADR
▲ 10.94%
3
Close
Oct 29, 2021
G1 Therapeutics
▼ 32.88%
5
Close
Oct 29, 2021
AT&T
▼ 9.00%
2
Close
Oct 29, 2021
Alteryx
▼ 34.01%
2
Close
Oct 29, 2021
Vertex Pharmaceuticals
▼ 15.19%
1
Close
Oct 27, 2021
Clovis Oncology
▼ 36.10%
2
Close
Oct 27, 2021
Allena Pharmaceuticals
▼ 36.54%
2
Close
Oct 27, 2021
Pacific Biosciences
▼ 29.61%
2
Close
Oct 27, 2021